GeneDx adopts 2023 Equity Inducement Plan, reserves 500,000 shares for new hires

GeneDx Holdings Corp.

Board adopted 2023 Equity Inducement Plan on July 21, 2023, reserving 500,000 shares of Class A common stock.
Plan is substantially similar to 2021 Equity Incentive Plan but compliant with Nasdaq Rule 5635(c)(4) for inducement awards.
Only new employees or rehires after a bona fide break are eligible for grants under the plan.
Forms of award agreements for nonstatutory stock options and restricted stock units were also adopted.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.